News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Deals
Pantarhei to Bid for Merck & Co., Inc.'s Organon Unit
February 14, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters) - Dutch bioscience company Pantarhei intends to bid for the bulk of U.S. company Merck's (MRK.N) Netherlands-based bioscience research unit Organan, the Dutch Financieele Dagblad reported on Monday.
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
Europe
Merck & Co.
Organon
MORE ON THIS TOPIC
Deals
Bluebird’s Private Equity Buyout Boosts Upfront Cash for Shareholders
May 15, 2025
·
1 min read
Obesity
Novo Doubles Down on Oral Obesity Meds With Septerna Deal Worth up to $2.4B
May 14, 2025
·
2 min read
·
Dan Samorodnitsky
Drug discovery
AbbVie Dives Further Into siRNA With $335M Upfront in ADARx Deal
May 14, 2025
·
2 min read
·
Annalee Armstrong
MASH
GSK Buys Phase III–Ready Liver Drug in Potential $2B Deal To Play in MASH Arena
May 14, 2025
·
2 min read
·
Tristan Manalac